Armata Pharmaceuticals is a Hold until Phase 3 AP-SA02 data, given a funding-dependent profile and limited margin for error.
Netflix's overall viewership may be up by 2%, but the streamer can't seem to shake concerns around its engagement metrics. That was one of the main takeaways from both the streamer's second-quarter ...
ScienceAlert on MSN
Your longevity may be shaped before you're even born, study reveals
(rattanakun/Canva) The science of longevity is an important topic for many researchers: how we might add years to our ...
Morning Overview on MSN
A drug hit its goal against an aggressive lymphoma in a late-stage trial
Patients with relapsed or refractory diffuse large B-cell lymphoma, one of the fastest-growing blood cancers, gained a new ...
AtaiBeckley is being acquired by Eli Lilly at $6.75/share plus a $2.50 CVR—see the deal terms, milestone risks, and pipeline ...
ECARX Holdings Inc. ("ECARX" or the "Company"), a leading global supplier of intelligent automotive computing and software solutions, today announced: an amendment deed (the "Amendment Deed") to ...
In the digital-intelligent era, traditional liberal arts education is undergoing profound paradigm changes. The integrated training of “technology + humanities” faces prominent problems such as ...
Objectives Body mass index (BMI) changes dynamically during early life, but whether BMI at specific developmental stages is ...
Equitable access to newer antibiotics relies on commitments to strengthening health systems’ infrastructure and facilitating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results